Self-Monitoring of Blood Glucose in Diabetes: From Evidence to Clinical Reality in Central and Eastern Europe—Recommendations from the International Central-Eastern European Expert Group
Open Access
- 1 July 2014
- journal article
- review article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 16 (7) , 460-475
Abstract
Self-monitoring of blood glucose (SMBG) is universally considered to be an integral part of type 1 diabetes management and crucial for optimizing the safety and efficacy of complex insulin regimens. This extends to type 2 diabetes patients on intensive insulin therapy, and there is also a growing body of evidence suggesting that structured SMBG is beneficial for all type 2 diabetes patients, regardless of therapy. However, access to SMBG can be limited in many countries in Central and Eastern Europe. A consensus group of diabetes experts from 10 countries in this region (with overlapping historical, political, and social environments)—Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Serbia, Slovakia, Slovenia, and Ukraine—was formed to discuss the role of SMBG across the spectrum of patients with diabetes. The group considered SMBG to be an essential tool that should be accessible to all patients with diabetes, including those with non–insulin-treated type 2 diabetes. The current article summarizes the evidence put forward by the consensus group and provides their recommendations for the appropriate use of SMBG as part of individualized patient management. The ultimate goal of these evidence-based recommendations is to help patients and providers in Central and Eastern Europe to make optimal use of SMBG in order to maximize the efficacy and safety of glucose-lowering therapies, to prevent complications, and to empower the patient to play a more active role in the management of their diabetes.Keywords
This publication has 90 references indexed in Scilit:
- Glucose Meters with Built-In Automated Bolus Calculator: Gadget or Real Value for Insulin-Treated Diabetic Patients?Diabetes Therapy, 2012
- Standards of Medical Care in Diabetes—2013Diabetes Care, 2012
- Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulinCochrane Database of Systematic Reviews, 2012
- Hypoglycemia and Cardiovascular RisksDiabetes Care, 2011
- Production of Functional Glucagon-Secreting α-Cells From Human Embryonic Stem CellsDiabetes, 2010
- Benefits of self‐monitoring blood glucose in the management of new‐onset Type 2 diabetes mellitus: The St Carlos Study, a prospective randomized clinic‐based interventional study with parallel groupsJournal of Diabetes, 2010
- Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trialBMJ, 2008
- Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trialBMJ, 2007
- Prediction of Severe HypoglycemiaDiabetes Care, 2007
- Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes StudyDiabetologia, 2007